Chelsea Therapeutics International Delisted
Chelsea Therapeutics International is a pharmaceutical company that focuses on developing and commercializing therapeutics for various human diseases. Their main goal is to acquire, develop, and market products for the treatment of conditions such as neurogenic orthostatic hypotension, autoimmune disorders, and cancer. They are currently working on the development of droxidopa for symptomatic NOH and other potential indications, as well as non-metabolized antifolate compounds for rheumatoid arthritis. Chelsea Therapeutics International aims to provide innovative solutions for patients suffering from these diseases.
Employee Number:
11-50
Founded Date:
2004
Funding Status:
M&A
Headquarters:
Charlotte, North Carolina, United States
Industry:
PharmTech
Technology:
Cancer